Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sancho

Showing results (281-290 of 289) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 289 results.
British Journal of Haematology|July 7, 2018
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithmCarlos Montalbán, Antonio Díaz-López, Alejandro Martín, et al.
ESMO Open|November 26, 2025
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPIF Martin-Moro, L Bento, J Marquet, et al.
British Journal of Haematology|November 30, 2019
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)Leyre Bento, Antonio Díaz-López, Gilberto Barranco, et al.
Journal of Neuro-Oncology|June 12, 2020
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric studyR Velasco, S Mercadal, N Vidal, et al.
British Journal of Haematology|January 21, 2017
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β<sub>2</sub> -microglobulin yields a more accurate GELTAMO-IPICarlos Montalbán, Antonio Díaz-López, Ivan Dlouhy, et al.
Hemasphere|October 9, 2024
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCLAlfredo Rivas-Delgado, Cristina López, Guillem Clot, et al.
Haematologica|March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL studyAlejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
British Journal of Haematology|August 8, 2017
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO groupSara Alonso-Álvarez, Laura Magnano, Miguel Alcoceba, et al.
Leukemia|August 15, 2017
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targetsK Karube, A Enjuanes, I Dlouhy, et al.
Pageof 29

Showing results (281-290 of 289) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 289 results.
British Journal of Haematology|July 7, 2018
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithmCarlos Montalbán, Antonio Díaz-López, Alejandro Martín, et al.
ESMO Open|November 26, 2025
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPIF Martin-Moro, L Bento, J Marquet, et al.
British Journal of Haematology|November 30, 2019
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)Leyre Bento, Antonio Díaz-López, Gilberto Barranco, et al.
Journal of Neuro-Oncology|June 12, 2020
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric studyR Velasco, S Mercadal, N Vidal, et al.
British Journal of Haematology|January 21, 2017
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β<sub>2</sub> -microglobulin yields a more accurate GELTAMO-IPICarlos Montalbán, Antonio Díaz-López, Ivan Dlouhy, et al.
Hemasphere|October 9, 2024
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCLAlfredo Rivas-Delgado, Cristina López, Guillem Clot, et al.
Haematologica|March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL studyAlejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
British Journal of Haematology|August 8, 2017
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO groupSara Alonso-Álvarez, Laura Magnano, Miguel Alcoceba, et al.
Leukemia|August 15, 2017
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targetsK Karube, A Enjuanes, I Dlouhy, et al.
Pageof 29